SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-18-016922
Filing Date
2018-09-12
Accepted
2018-09-12 16:09:15
Documents
69
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K inbp20180630_10k.htm 10-K 1199211
2 EXHIBIT 21 SUBSIDIARIES ex_123706.htm EX-21 5506
3 EXHIBIT 23.1 ex_123707.htm EX-23.1 2795
4 EXHIBIT 31.1 CEO CERTIFICATION ex_123708.htm EX-31.1 15926
5 EXHIBIT 31.2 CFO CERTIFICATION ex_123709.htm EX-31.2 15965
6 EXHIBIT 32.1 CEO CERTIFICATION ex_123710.htm EX-32.1 6608
7 EXHIBIT 32.2 CFO CERTIFICATION ex_123711.htm EX-32.2 6941
  Complete submission text file 0001437749-18-016922.txt   6340974

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT inbp-20180630.xml EX-101.INS 1310348
9 XBRL TAXONOMY EXTENSION SCHEMA inbp-20180630.xsd EX-101.SCH 58270
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inbp-20180630_cal.xml EX-101.CAL 49952
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inbp-20180630_def.xml EX-101.DEF 460778
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE inbp-20180630_lab.xml EX-101.LAB 391564
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inbp-20180630_pre.xml EX-101.PRE 483536
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-31668 | Film No.: 181066961
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1